SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-159281
Filing Date
2018-05-10
Accepted
2018-05-10 16:34:50
Documents
49
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d361020d10q.htm 10-Q 563312
2 EX-31.1 d361020dex311.htm EX-31.1 6088
3 EX-31.2 d361020dex312.htm EX-31.2 6092
4 EX-32.1 d361020dex321.htm EX-32.1 5370
  Complete submission text file 0001193125-18-159281.txt   2524133

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20180331.xml EX-101.INS 388687
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20180331.xsd EX-101.SCH 31612
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20180331_cal.xml EX-101.CAL 48531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20180331_def.xml EX-101.DEF 86824
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20180331_lab.xml EX-101.LAB 251034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20180331_pre.xml EX-101.PRE 166382
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 18823100
SIC: 2834 Pharmaceutical Preparations